HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modified High-Molecular-Weight Hyaluronan Promotes Allergen-Specific Immune Tolerance.

Abstract
The extracellular matrix in asthmatic lungs contains abundant low-molecular-weight hyaluronan, and this is known to promote antigen presentation and allergic responses. Conversely, high-molecular-weight hyaluronan (HMW-HA), typical of uninflamed tissues, is known to suppress inflammation. We investigated whether HMW-HA can be adapted to promote tolerance to airway allergens. HMW-HA was thiolated to prevent its catabolism and was tethered to allergens via thiol linkages. This platform, which we call "XHA," delivers antigenic payloads in the context of antiinflammatory costimulation. Allergen/XHA was administered intranasally to mice that had been sensitized previously to these allergens. XHA prevents allergic airway inflammation in mice sensitized previously to either ovalbumin or cockroach proteins. Allergen/XHA treatment reduced inflammatory cell counts, airway hyperresponsiveness, allergen-specific IgE, and T helper type 2 cell cytokine production in comparison with allergen alone. These effects were allergen specific and IL-10 dependent. They were durable for weeks after the last challenge, providing a substantial advantage over the current desensitization protocols. Mechanistically, XHA promoted CD44-dependent inhibition of nuclear factor-κB signaling, diminished dendritic cell maturation, and reduced the induction of allergen-specific CD4 T-helper responses. XHA and other potential strategies that target CD44 are promising alternatives for the treatment of asthma and allergic sinusitis.
AuthorsJohn A Gebe, Koshika Yadava, Shannon M Ruppert, Payton Marshall, Paul Hill, Ben A Falk, Johanna M Sweere, Hongwei Han, Gernot Kaber, Ingrid A Harten, Carlos Medina, Katalin Mikecz, Steven F Ziegler, Swathi Balaji, Sundeep G Keswani, Vinicio A de Jesus Perez, Manish J Butte, Kari Nadeau, William A Altemeier, Neil Fanger, Paul L Bollyky
JournalAmerican journal of respiratory cell and molecular biology (Am J Respir Cell Mol Biol) Vol. 56 Issue 1 Pg. 109-120 (01 2017) ISSN: 1535-4989 [Electronic] United States
PMID27598620 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Allergens
  • Anti-Inflammatory Agents
  • Cross-Linking Reagents
  • Hyaluronan Receptors
  • NF-kappa B
  • Sulfhydryl Compounds
  • Interleukin-10
  • Hyaluronic Acid
Topics
  • Allergens (immunology)
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Bone Marrow Cells (cytology)
  • Cell Differentiation (drug effects)
  • Cell Nucleus (drug effects, metabolism)
  • Cell Proliferation (drug effects)
  • Cross-Linking Reagents (metabolism)
  • Dendritic Cells (drug effects)
  • Hyaluronan Receptors (metabolism)
  • Hyaluronic Acid (chemistry, pharmacology)
  • Immune Tolerance (drug effects)
  • Immunization
  • Interleukin-10
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Molecular Weight
  • NF-kappa B (metabolism)
  • Pneumonia (immunology, pathology, physiopathology)
  • Protein Transport (drug effects)
  • Sulfhydryl Compounds (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: